<DOC>
	<DOCNO>NCT01180348</DOCNO>
	<brief_summary>The dermatological treatment reduce facial wrinkle injectable drug Botulift ( botulinum toxin type A - Laboratório Químico Farmacêutico BergamoLtd . ) inferior activity compare Botox ® ( botulinum toxin - Allergan Inc. ) clinical trial .</brief_summary>
	<brief_title>Efficacy Safety New Botulinum Toxin Type A Treatment Facial Expression Lines</brief_title>
	<detailed_description>The study evaluate non-inferiority clinical improvement intensity expression line 16 week drug Botulift ( Laboratório Químico Farmacêutico Bergamo Ltd. ) compare Botox ® ( Allergan Inc. ) . So homogeneity group opt use female patient glabellar wrinkle grade 2 ( moderate ) 3 ( severe ) Scale Standard Facial Wrinkles , establish Honecker et al . ( 2003 ) . The first area face perceive mime glabellar complex , locate space eyebrow , wrinkle eventually show ( Almeida et al. , 2010 ) . Patients evaluate visit , doctor Principal Investigator digital photo glabellar region maximum contraction relaxation obtain use apparatus Visia ( Canfield Imaging Systems , version 4.0.2 ) analysis random team dermatologist .</detailed_description>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Patients agree study procedure sign free TCLE ; Adult patient female 18 65 year , regardless social condition ; skin phototype I IV ; With good mental physical health ; Patients treat botulinum toxin type A ; Patients agree abstain physical activity period 24 hour , previous subsequent initiation study ; Patients present screen visit , wrinkle glabellar region class 2 3 Table Wrinkles Pattern Classification , diagnose clinically dermatologist . Patients class 0 1 Table Pattern Classification Wrinkle ; Patients disorder disease might interfere neuromuscular function ( myasthenia gravis LambertEaton syndrome ) ; Patients treat antibiotic ( aminoglycosides ) muscle relaxant ; Patients preexist condition ptosis scar area assess , may endanger health patient result study ; Patients make treatment fill glabellar region ( retinoic acid , collagen ) ; Patients treat dermatological peeling úlitmos three month ; Patients use treatment dermacosmetics agent anti age ( vitamin C pure retinoids flavanoids acid hyaluronic others ) use past 3 month Patients know hypersensitivity component study drug ; Pregnant lactate woman ;</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Wrinkles , glabellar , facial .</keyword>
</DOC>